DropsTab logo - blue line depicting the shape of a water drop with Christmas decoration
M. Cap$2.95 T −1.05%24h Vol$178.88 B 20.37%BTC$86,635.15 0.26%ETH$2,831.70 −3.00%S&P 500$6,724.13 −1.13%Gold$4,336.16 0.06%BTC Dominance58.74%
  • N/T

Tharimmune 

Market data is not available yet

At the moment, the Project may be in preliminary stages (Seed, Private Sale, Presale, ICO). The information provided below may be inaccurate (Beta) and being updated.

Investors

X Followers

OverviewExchangesFundraisingVesting
Activities
Research

Fundraising

See More
--USD ROI
--BTC ROI
--ETH ROI
ICO Price
--
Funds Raised
$540.00 M
Tokens Sold
--

About Tharimmune

Tharimmune is a biotechnology company developing new drugs for rare immune and inflammatory diseases, as well as cancer. It uses cutting-edge methods, such as multi-target antibodies, and targets areas of medicine where effective solutions are currently scarce.

Official Links

Trending Assets

Nothing in Trending Today